• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Intracameral Chemotherapy for Globe Salvage in Retinoblastoma with Secondary Anterior Chamber Invasion.

作者信息

Munier Francis L, Moulin Alexandre, Gaillard Marie-Claire, Bongiovanni Massimo, Decembrini Sarah, Houghton Susan, Beck-Popovic Maja, Stathopoulos Christina

机构信息

Jules-Gonin Eye Hospital, Fondation Asile des Aveugles, University of Lausanne, Lausanne, Switzerland.

Jules-Gonin Eye Hospital, Fondation Asile des Aveugles, University of Lausanne, Lausanne, Switzerland.

出版信息

Ophthalmology. 2018 Apr;125(4):615-617. doi: 10.1016/j.ophtha.2017.11.010. Epub 2017 Dec 6.

DOI:10.1016/j.ophtha.2017.11.010
PMID:29208450
Abstract
摘要

相似文献

1
Intracameral Chemotherapy for Globe Salvage in Retinoblastoma with Secondary Anterior Chamber Invasion.前房内化疗用于挽救继发前房侵犯的视网膜母细胞瘤眼球
Ophthalmology. 2018 Apr;125(4):615-617. doi: 10.1016/j.ophtha.2017.11.010. Epub 2017 Dec 6.
2
Clinicopathologic review of enucleated eyes after intra-arterial chemotherapy with melphalan for advanced retinoblastoma.美法仑动脉内化疗治疗晚期视网膜母细胞瘤后摘除眼球的临床病理回顾
Arch Ophthalmol. 2010 Dec;128(12):1619-23. doi: 10.1001/archophthalmol.2010.296.
3
Management of advanced retinoblastoma with intravenous chemotherapy then intra-arterial chemotherapy as alternative to enucleation.静脉化疗联合动脉化疗治疗晚期视网膜母细胞瘤，以替代眼球摘除术。
Retina. 2013 Nov-Dec;33(10):2103-9. doi: 10.1097/IAE.0b013e318295f783.
4
Intra-Arterial Chemotherapy for Retinoblastoma: A Single-Center Experience.视网膜母细胞瘤的动脉内化疗：单中心经验
Ophthalmologica. 2015;234(4):227-32. doi: 10.1159/000439357. Epub 2015 Sep 15.
5
Not All Seeds Are Created Equal: Seed Classification Is Predictive of Outcomes in Retinoblastoma.并非所有种子都生来平等：种子分类可预测视网膜母细胞瘤的结局。
Ophthalmology. 2017 Dec;124(12):1817-1825. doi: 10.1016/j.ophtha.2017.05.034. Epub 2017 Jun 24.
6
Malignant transformation of retinocytoma treated with intra-arterial chemptherapy.经动脉化疗治疗的视网膜细胞瘤的恶性转化
Can J Ophthalmol. 2016 Jun;51(3):e105-7. doi: 10.1016/j.jcjo.2015.12.023.
7
Intravitreal melphalan for persistent or recurrent retinoblastoma vitreous seeds: preliminary results.眼内注射美法仑治疗持续性或复发性视网膜母细胞瘤玻璃体内播散：初步结果。
JAMA Ophthalmol. 2014 Mar;132(3):319-25. doi: 10.1001/jamaophthalmol.2013.7666.
8
Complete regression of retinoblastoma following intra-arterial chemotherapy.动脉内化疗后视网膜母细胞瘤完全消退。
J Pediatr Ophthalmol Strabismus. 2011 Jun 7;48 Online:e23-5. doi: 10.3928/01913913-20110531-02.
9
Intra-arterial chemotherapy for retinoblastoma: Our first three-and-a-half years' experience in Malaysia.眼内动脉化疗治疗视网膜母细胞瘤：我们在马来西亚的头 3 年半经验。
PLoS One. 2020 May 1;15(5):e0232249. doi: 10.1371/journal.pone.0232249. eCollection 2020.
10
Histopathology of retinoblastoma eyes enucleated after intra-arterial chemotherapy.经动脉化疗后摘除的视网膜母细胞瘤眼的组织病理学。
Br J Ophthalmol. 2020 Aug;104(8):1171-1175. doi: 10.1136/bjophthalmol-2019-315209. Epub 2019 Nov 1.

引用本文的文献

1
Spatial transcriptomics of retinoblastoma: a visual window on intra-patient heterogeneity.视网膜母细胞瘤的空间转录组学：洞察患者内部异质性的视觉窗口。
BMC Cancer. 2025 Sep 2;25(1):1410. doi: 10.1186/s12885-025-14814-5.
2
Intraocular Surgery for Retinoblastoma: An Evaluation of Current Evidence.视网膜母细胞瘤的眼内手术：当前证据评估
Ocul Oncol Pathol. 2024 Dec;10(4):234-246. doi: 10.1159/000538626. Epub 2024 Jun 24.
3
Retinoblastoma - A comprehensive review, update and recent advances.视网膜母细胞瘤——全面综述、更新及最新进展。
Indian J Ophthalmol. 2024 Jun 1;72(6):778-788. doi: 10.4103/IJO.IJO_2414_23. Epub 2024 May 24.
4
Nanoparticle-based delivery systems as emerging therapy in retinoblastoma: recent advances, challenges and prospects.基于纳米颗粒的递送系统在视网膜母细胞瘤中的新兴疗法：最新进展、挑战与前景
Nanoscale Adv. 2023 Aug 15;5(18):4628-4648. doi: 10.1039/d3na00462g. eCollection 2023 Sep 12.
5
Translational screening platform to evaluate chemotherapy in combination with focal therapy for retinoblastoma.用于评估化疗联合视网膜母细胞瘤局部治疗的转化筛选平台。
Cancer Sci. 2023 Sep;114(9):3728-3739. doi: 10.1111/cas.15878. Epub 2023 Jun 20.
6
Spotlight on Targeted Chemotherapy in Retinoblastoma: Safety, Efficacy, and Patient Outcomes.视网膜母细胞瘤靶向化疗的聚焦：安全性、疗效及患者预后
Onco Targets Ther. 2022 Dec 22;15:1545-1561. doi: 10.2147/OTT.S370878. eCollection 2022.
7
Ten-year experience with intracameral chemotherapy for aqueous seeding in retinoblastoma: long-term efficacy, safety and toxicity.眼内化疗治疗视网膜母细胞瘤眼内播散 10 年的经验：长期疗效、安全性和毒性。
Br J Ophthalmol. 2023 Dec 18;108(1):124-130. doi: 10.1136/bjo-2022-322492.
8
GSDME Increases Chemotherapeutic Drug Sensitivity by Inducing Pyroptosis in Retinoblastoma Cells.GSDME 通过诱导视网膜母细胞瘤细胞发生细胞焦亡增加化疗药物敏感性。
Oxid Med Cell Longev. 2022 Mar 29;2022:2371807. doi: 10.1155/2022/2371807. eCollection 2022.
9
Treatment of Retinoblastoma: What Is the Latest and What Is the Future.视网膜母细胞瘤的治疗：最新进展与未来展望
Front Oncol. 2022 Apr 1;12:822330. doi: 10.3389/fonc.2022.822330. eCollection 2022.
10
Current Indications of Secondary Enucleation in Retinoblastoma Management: A Position Paper on Behalf of the European Retinoblastoma Group (EURbG).视网膜母细胞瘤治疗中二次眼球摘除术的当前指征：代表欧洲视网膜母细胞瘤研究组（EURbG）发布的立场文件
Cancers (Basel). 2021 Jul 6;13(14):3392. doi: 10.3390/cancers13143392.